Evaluation of Impression Accuracy: Digital Scanner Versus Analog Technique
Evaluation of the Accuracy of Intraoral Scanner Versus Analog Impression in Implant Supported Rehabilitations Performed With Flapless Computer-Guided Implantology
1 other identifier
observational
51
1 country
1
Brief Summary
The goal of this study is to evaluate the accuracy of intraoral impressions obtained using the Trios 3Shape® and Carestream CS 3600™ scanners, as well as traditional analog impressions using polyvinyl siloxane (PVS), in comparison to a gold standard represented by a laboratory scanner in 51 dental models from 42 patients affected by partial edentulism who required at least two implants. Researchers compare Trios 3Shape®, Carestream CS 3600™ and polyvinyl siloxane (PVS) to see if there is a different accuracy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2022
CompletedFirst Submitted
Initial submission to the registry
May 21, 2025
CompletedFirst Posted
Study publicly available on registry
November 28, 2025
CompletedNovember 28, 2025
May 1, 2025
5.4 years
May 21, 2025
November 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical and radiological evaluation of soft tissues and bone level in implant supported rehabilitations performed with Flapless Computer-Guided implantology. A prospective clinical study.
The statistical analyses were performed using AnalystSoft StatPlus®. Using GOM Inspect by Zeiss®, the mean deviation values from the reference file were calculated for each model. They were expressed in absolute terms. In our study, for each of the three test techniques (TRIOS®-3Shape, CS 3600® Carestream Dental, and PVS), the average of the values obtained from the superimpositions of 51 models was calculated, resulting in the mean deviation of each method from the reference. For data analysis, a one-way ANOVA test and a two-sample Z-test were applied, with a significance level (α) set at 0.05. These tests were used both to compare the mean distances and to assess the standard deviations of the deviations. Each technique was considered accurate if its mean deviation was less than 30 μm.
Patients included in this prospective study were recruited from 2017 to 2022
Study Arms (3)
TRIOS®-3Shape Group
Participants whose models were scanned using the TRIOS®-3Shape intraoral digital scanner. The deviation from the reference model was calculated to assess the accuracy of this technique.
CS 3600® Carestream Group
Participants whose models were scanned using the CS 3600® Carestream Dental intraoral scanner. The deviation from the reference model was analyzed to evaluate the technique's precision.
PVS Analog Impression Group
Participants whose impressions were taken using conventional polyvinylsiloxane (PVS) material. Cast models were scanned and compared to the reference to determine the accuracy of analog impressions.
Interventions
impression taken by intraoral scanner
Eligibility Criteria
The study population consisted of patients seeking implant treatment at the Implantology and Prosthodontics Department of the Giorgio Vogel Odontostomatological Clinic, ASST Santi Paolo e Carlo, Milan.
You may qualify if:
- Age between 18 and 80 years;
- Implant placement in healed bone sites (at least 8 weeks post-tooth extraction or at least 6 months after regenerative procedures), allowing guided implant insertion of at least 3.3 mm in diameter or 8.5 mm in length;
- Implant site without ongoing infections or dental extraction residues;
- Good systemic health conditions and adequate oral hygiene;
- Periapical and periodontal health of opposing teeth/implants in occlusion;
- Edentulism of at least two adjacent dental elements.
You may not qualify if:
- Ongoing diseases requiring prolonged use of corticosteroids;
- Leukocyte dysfunction or deficiencies;
- Severe hemophilia;
- Current pregnancy;
- Past and/or current head/neck radiotherapy and/or chemotherapy;
- Renal insufficiency;
- Past and/or current use of bisphosphonates;
- Uncompensated endocrine disorders;
- Physical disabilities preventing adequate oral hygiene;
- Alcohol abuse and drug use;
- Smokers (\>10 cigarettes/day);
- Untreated periodontitis;
- Mucosal diseases (e.g., erosive Lichen Planus);
- Severe parafunctional habits (e.g., bruxism or clenching);
- Persistent intraoral infections;
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinica Odontoiatrica Giorgio Vogel (Università degli studi di Milano)
Milan, Italy, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Reasearcher
Study Record Dates
First Submitted
May 21, 2025
First Posted
November 28, 2025
Study Start
July 15, 2017
Primary Completion
December 15, 2022
Study Completion
December 15, 2022
Last Updated
November 28, 2025
Record last verified: 2025-05